8QJ5
Crystal structure of the Levansucrase beta from Pseudomonas syringae pv. actinidiae
Summary for 8QJ5
| Entry DOI | 10.2210/pdb8qj5/pdb |
| Descriptor | Glutamate 5-kinase, PHOSPHATE ION, polyethylene glycol, ... (8 entities in total) |
| Functional Keywords | beta-propeller, levan, glycoside hydrolase, transferase |
| Biological source | Pseudomonas syringae pv. actinidiae |
| Total number of polymer chains | 2 |
| Total formula weight | 97513.86 |
| Authors | Ferraroni, M.,Peritore, L. (deposition date: 2023-09-12, release date: 2024-09-25, Last modification date: 2025-10-15) |
| Primary citation | Cicchi, C.,Pazzagli, L.,Paoli, P.,Campigli, S.,Marchi, G.,Cardona, F.,Clemente, F.,Pavone, S.,Ferraroni, M.,Canovai, A.,Matassini, C.,Luti, S. Molecular Basis of Pseudomonas syringae pv actinidiae Levansucrase Inhibition by a Multivalent Iminosugar. J.Agric.Food Chem., 73:15981-15992, 2025 Cited by PubMed Abstract: Levansucrases are a class of polysaccharide-processing enzymes widely distributed among plant pathogenic bacteria, such as and . Therefore, the modulation of levansucrase activity could represent a new strategy to reduce the microbial survival of such bacteria. Herein, we identified a tetravalent pyrrolidine iminosugar (TPIS) as the first levansucrase inhibitor described to date. TPIS reversibly inhibits sucrose hydrolysis and levan polymerization of levansucrase derived from different bacterial genotypes of , showing competitive behavior and an inhibition constant () in the micromolar range. Interestingly, the monovalent pyrrolidine iminosugar (PIS) analogue shows negligible inhibition, suggesting that multivalency plays a pivotal role in the interaction with levansucrase. To gain insight into the binding mechanism, the X-ray crystal structures of the beta levansucrase isoform from pv (Psa) in its native form and in complex with TPIS were solved, confirming TPIS as a competitive inhibitor of levansucrases. Only a portion of TPIS, corresponding to one chain of the tetravalent iminosugar derivative, was visible in the electron density maps. Nevertheless, our structural data provided an adequate comprehension of the inhibitor/enzyme interactions, sufficient to exclude some of the possible inhibition mechanisms justifying a multivalent effect and pave the way for the development of new, more potent inhibitors. PubMed: 40349214DOI: 10.1021/acs.jafc.5c01947 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.63 Å) |
Structure validation
Download full validation report






